Method for treatment of neoplastic diseases with alpha-keto glutarate and/or salts thereof
PL379512A1
New methods and their application
PL372183A1
Anticancer drug as well as application of the anticancer drug
PL371081A1
Pharmaceutical compound with the effect on the growth and the mineralization of osseous-skeleton system and on mature years bone and cartilage diseases among humans and animals, and method for its application
PL370937A1
Nutritional and/or pharmaceutical preparation for use in the prevention and treatment for the deficiency in absorption of microelements from the alimentary canal as well as application of pharmaceutical preparation stimulating absorption of microelements
PL369552A1
Pharmaceutical or/and nutrient or/and laboratory preparation for increasing, supporting the functioning of nerve cells and nervous system as well as application of pharmaceutical or/and nutrient or/and laboratory preparation in protection of the functions
PL368573A1
Pharmaceutical compound influencing growth and mineralization processes in the axial and the appendicular skeleton as well as bone diseases of mature years among humans and animals as well as application of the pharmaceutical compound in the process of growth and mineralization of axial and appendicular skeleton and bone diseases of mature years among humans and animals
PL368572A1
Pharmaceutical compound for prevention and therapy of increased level of cholesterol, ldl and triglycerides as well as application of the pharmaceutical compound as an agent acting against atherosclerosis and used in circulatory system affections
PL368179A1
Proteollytic method for processing proteins and protein hydrolysis products, enriched with exogenous, semi-exogenous and conditionally exogenous amino acids for making therapeutic preparation used in normal and medicinal diets
